IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · IEX Real-Time Price · USD
0.680
-0.062 (-8.38%)
Jul 22, 2024, 10:02 AM EDT - Market open

IceCure Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Market Capitalization
334957107--
Market Cap Growth
4.39%-14.46%-46.45%---
Enterprise Value
25383482-8-6
PE Ratio
--3.33-3.36-10.77--
PS Ratio
10.9715.1318.5125.76--
PB Ratio
3.084.012.253.96--
P/FCF Ratio
-4.31-3.76-3.76-8.11--
P/OCF Ratio
-4.40-3.90-3.99-8.46--
EV/Sales Ratio
7.7811.8810.9419.79-2.03-3.41
EV/EBITDA Ratio
-2.97-2.52-2.05-8.531.921.17
EV/EBIT Ratio
-2.90-2.46-2.02-8.421.891.16
EV/FCF Ratio
-3.49-2.95-2.22-6.232.002.65
Debt / Equity Ratio
0.050.050.020.030.060.07
Debt / EBITDA Ratio
-0.04-0.04-0.04-0.09-0.08-0.05
Debt / FCF Ratio
-0.04-0.05-0.04-0.07-0.08-0.11
Quick Ratio
2.712.885.546.492.231.63
Current Ratio
3.393.666.497.542.581.93
Asset Turnover
0.180.150.120.200.44-
Interest Coverage
---70.04-56.87--
Return on Equity (ROE)
-101.70%-87.00%-82.30%-60.70%-83.50%-
Return on Assets (ROA)
-77.70%-68.60%-66.10%-46.50%-42.60%-
Return on Capital (ROIC)
-125.31%-122.05%-64.33%-34.89%-69.26%-135.49%
Earnings Yield
-40.50%-30.00%-29.74%-9.28%--
FCF Yield
-35.48%-26.62%-26.59%-12.32%--
Buyback Yield / Dilution
-2.44%-23.29%-29.66%-66.67%-25.75%-
Total Shareholder Return
-2.44%-23.29%-29.66%-66.67%-25.75%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).